Koers Abbott Laboratories
Aandelen
ABT
US0028241000
Medische apparatuur, benodigdheden & distributie
Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
113,7 USD | +0,16% | +1,93% | +3,26% |
Omzet 2024 * | 41,98 mld. 38,9 mld. | Omzet 2025 * | 44,97 mld. 41,67 mld. | Marktkapitalisatie | 197 mld. 183 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 6 mld. 5,56 mld. | Nettowinst (verlies) 2025 * | 6,94 mld. 6,43 mld. | EV/omzet 2024 * | 4,77 x |
Nettoschuld 2024 * | 3,14 mld. 2,91 mld. | Nettoliquiditeiten 2025 * | 1,23 mld. 1,14 mld. | EV/omzet 2025 * | 4,36 x |
K/w-verhouding 2024 * |
32,9
x | K/w-verhouding 2025 * |
28,5
x | Werknemers | 114.000 |
Dividendrendement 2024 * |
1,9% | Dividendrendement 2025 * |
2,04% | Vrij verhandelbaar | 86,76% |
Recentste transcriptie over Abbott Laboratories
1 dag | +0,16% | ||
1 week | +1,93% | ||
Lopende maand | -4,20% | ||
1 maand | -5,32% | ||
3 maanden | +2,95% | ||
6 maanden | +15,84% | ||
Lopend jaar | +3,26% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Robert Ford
CEO | Chief Executive Officer | 50 | 01-01-15 |
Philip Boudreau
DFI | Director of Finance/CFO | 51 | 01-01-97 |
Scott House
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-90 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Daniel Starks
BRD | Director/Board Member | 69 | 16-02-17 |
John Stratton
BRD | Director/Board Member | 63 | 29-06-17 |
Nancy McKinstry
BRD | Director/Board Member | 65 | 09-12-11 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
7.18% | 18 M€ | +6,77% | - | |
5.19% | 2 M€ | -.--% | ||
3.00% | 2 M€ | -.--% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
28-03-24 | 113,7 | +0,16% | 5 278 215 |
27-03-24 | 113,5 | +1,78% | 7 533 356 |
26-03-24 | 111,5 | +1,35% | 7 770 829 |
25-03-24 | 110 | -0,51% | 6 622 414 |
22-03-24 | 110,6 | -0,84% | 5 387 719 |
uitgestelde koers Nyse, 28 maart 2024 om 21:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+3,26% | 197 mld. | |
+5,79% | 116 mld. | |
+1,48% | 71,49 mld. | |
+11,77% | 53,47 mld. | |
+18,31% | 48,42 mld. | |
+6,33% | 43,64 mld. | |
+12,38% | 28,97 mld. | |
+9,76% | 28,47 mld. | |
+8,45% | 27,12 mld. | |
+18,09% | 27,08 mld. |